These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1534698)
41. Physical constraints in the synthesis of glycogen that influence its structural homogeneity: a two-dimensional approach. Meléndez R; Meléndez-Hevia E; Mas F; Mach J; Cascante M Biophys J; 1998 Jul; 75(1):106-14. PubMed ID: 9649371 [TBL] [Abstract][Full Text] [Related]
42. Program and abstracts for a symposium on the physiologic, metabolic, and immunologic actions of interleukin-1. Ann Arbor, June 4-6, 1985. J Leukoc Biol; 1985 Jun; 37(6):683-761. PubMed ID: 3872920 [No Abstract] [Full Text] [Related]
43. Folding pathway of interleukin-1 beta. Jennings P; Roy M; Heidary D; Gross L Nat Struct Biol; 1998 Jan; 5(1):11. PubMed ID: 9437419 [No Abstract] [Full Text] [Related]
46. Structural Basis of IL-1 Family Cytokine Signaling. Fields JK; Günther S; Sundberg EJ Front Immunol; 2019; 10():1412. PubMed ID: 31281320 [TBL] [Abstract][Full Text] [Related]
47. The role of interleukin-1 in general pathology. Kaneko N; Kurata M; Yamamoto T; Morikawa S; Masumoto J Inflamm Regen; 2019; 39():12. PubMed ID: 31182982 [TBL] [Abstract][Full Text] [Related]
48. MytiLec, a Mussel R-Type Lectin, Interacts with Surface Glycan Gb3 on Burkitt's Lymphoma Cells to Trigger Apoptosis through Multiple Pathways. Hasan I; Sugawara S; Fujii Y; Koide Y; Terada D; Iimura N; Fujiwara T; Takahashi KG; Kojima N; Rajia S; Kawsar SM; Kanaly RA; Uchiyama H; Hosono M; Ogawa Y; Fujita H; Hamako J; Matsui T; Ozeki Y Mar Drugs; 2015 Dec; 13(12):7377-89. PubMed ID: 26694420 [TBL] [Abstract][Full Text] [Related]
49. Altered backbone and side-chain interactions result in route heterogeneity during the folding of interleukin-1β (IL-1β). Capraro DT; Lammert H; Heidary DK; Roy M; Gross LA; Onuchic JN; Jennings PA Biophys J; 2013 Aug; 105(4):975-83. PubMed ID: 23972849 [TBL] [Abstract][Full Text] [Related]
50. Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling. Vergoten G; Zanetta JP Glycoconj J; 2007 Jul; 24(4-5):183-93. PubMed ID: 17340198 [TBL] [Abstract][Full Text] [Related]
51. Quantitative analysis of the conservation of the tertiary structure of protein segments. Ruan J; Chen K; Tuszynski JA; Kurgan LA Protein J; 2006 Jul; 25(5):301-15. PubMed ID: 16957991 [TBL] [Abstract][Full Text] [Related]
53. Structure and function of interleukin-1, based on crystallographic and modeling studies. Veerapandian B Biophys J; 1992 Apr; 62(1):112-5. PubMed ID: 1534698 [No Abstract] [Full Text] [Related]
54. [Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-1]. Onozaki K Nihon Rinsho; 1988 May; 46(5):994-1001. PubMed ID: 2970559 [No Abstract] [Full Text] [Related]
55. The interleukin-1 system: receptors, ligands and signals. Dower SK; Sims JE; Cerretti DP; Bird TA Chem Immunol; 1992; 51():33-64. PubMed ID: 1533129 [No Abstract] [Full Text] [Related]
56. The three-dimensional structure of human interleukin-1 beta refined to 2.0 A resolution. Priestle JP; Schär HP; Grütter MG Prog Clin Biol Res; 1990; 349():297-307. PubMed ID: 2144642 [No Abstract] [Full Text] [Related]